Joshua Ewell, DO

AI
The John Henry Generation: The last of the radiologists, Part 2
In part 2 of his two-part series, Joshua Ewell, DO, discuss economic pressures, philosophical and spiritual implications, and closing thoughts on the future of AI in radiology.
January 10, 2025
Ewell Joshua Thumbnail
AI
The John Henry Generation: The last of the radiologists, Part 1
In a two-part series, radiologist Joshua Ewell, DO, discusses the looming crisis in radiology, advances in AI, and and the future of radiologists.
January 9, 2025
Ewell Joshua Thumbnail
Page 1 of 1
Top Stories
Mammo Reading 400
Womens Imaging
More women welcome AI assistance for mammography exams
More women are willing to have AI assistance for their breast cancer screening exams.
Pet Scan Patient
Molecular Imaging
PET scans predict outcomes for patients undergoing CAR T-cell therapy
Sarcopenia
CT
Abdominal CT imaging shows potential for diagnosing sarcopenia
Lung Cancer
AI
How can AI best help in LDCT lung cancer screening?
Images of a 69-year-old man diagnosed with prostate cancer who had a history of endocrine therapy for two years. (a) The maximum intensity projection (MIP) image of F-18 FDG showed moderate radiotracer uptake in a thoracic vertebra. (e) The MIP image of Ga-68 DOTA-IBA demonstrated more lesions in the cervical vertebra and pelvis. (b) An osteoblastic lesion in the C3 vertebra right attachment (curved arrows) was negative on F-18 FDG (SUVmax = 2.0) and positive on Ga-68 DOTA-IBA (SUVmax = 8.7). (c) Another osteoblastic lesion in the T10 vertebra left side (arrowheads) was both positive on F-18 FDG (SUVmax = 5.2) and positive on Ga-68 DOTA-IBA (SUVmax = 35.0). (d) Osteoblastic lesions in bilateral ilium (dotted arrows and arrows) were negative on F-18 FDG (left: SUVmax = 1.4, right: SUVmax = 1.6) and positive on Ga-68 DOTA-IBA (left: SUVmax = 7.6, right: SUVmax = 8.7). Follow-up imaging three months later confirmed the presence of these bone metastases. Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of Scientific Reports.
Molecular Imaging
New theranostics PET tracer shows promise
More in Authors
Deborah Barnes
June 7, 2024
Page 1 of 1